ReviewNeuro-oncology2025

The use of minor response, volumetric assessment, and growth rate kinetics as endpoints in grade 1-3 glioma clinical trials: a RANO perspective.

Martin J van den Bent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.